Jin Medical International Ltd. (ZJYL)
NASDAQ: ZJYL · IEX Real-Time Price · USD
3.010
-0.100 (-3.22%)
Jun 20, 2024, 2:28 PM EDT - Market open

Jin Medical International Income Statement

Millions USD. Fiscal year is Oct - Sep.
Year
202320222021
Revenue
19.8219.1920.76
Revenue Growth (YoY)
3.29%-7.58%-
Cost of Revenue
13.0412.9914.4
Gross Profit
6.786.26.36
Selling, General & Admin
2.372.182.16
Research & Development
1.541.891.57
Operating Expenses
3.924.073.73
Operating Income
2.872.132.63
Interest Expense / Income
-0.18-0.180.01
Other Expense / Income
-0.17-0.43-0.26
Pretax Income
3.222.742.88
Income Tax
0.340.040.25
Net Income
2.882.712.63
Net Income Growth
6.34%2.84%-
Shares Outstanding (Basic)
145135135
Shares Outstanding (Diluted)
145135135
Shares Change
7.51%--
EPS (Basic)
0.020.020.02
EPS (Diluted)
0.020.020.02
Free Cash Flow
31.545.8
Free Cash Flow Per Share
0.020.010.04
Gross Margin
34.23%32.30%30.64%
Operating Margin
14.47%11.10%12.67%
Profit Margin
14.52%14.10%12.67%
Free Cash Flow Margin
15.15%8.03%27.93%
Effective Tax Rate
10.67%1.32%8.63%
EBITDA
3.272.923.24
EBITDA Margin
16.47%15.23%15.59%
Depreciation & Amortization
0.230.360.35
EBIT
3.042.562.89
EBIT Margin
15.33%13.35%13.92%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).